GRM1 and glioma: Several studies have shown that mGluR1, mGluR2, or mGluR3 signaling are linked to the increased tumorigenicity and metastatic potential of gliomas through activation of the MAPK and PI3K/AKT pathways (Table 1) [88,91,93,119].